Asmaa El-Kenawi

1.9k total citations · 1 hit paper
23 papers, 1.2k citations indexed

About

Asmaa El-Kenawi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Asmaa El-Kenawi has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Asmaa El-Kenawi's work include Cancer, Hypoxia, and Metabolism (5 papers), Immune cells in cancer (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Asmaa El-Kenawi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Immune cells in cancer (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Asmaa El-Kenawi collaborates with scholars based in Egypt, United States and Italy. Asmaa El-Kenawi's co-authors include Azza B. El‐Remessy, Robert J. Gillies, Shari Pilon‐Thomas, Arig Ibrahim‐Hashim, Kimberly A. Luddy, Shonagh Russell, Mehdi Damaghi, Krithika N. Kodumudi, James J. Mulé and Jonathan W. Wojtkowiak and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Asmaa El-Kenawi

21 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy

2016 468 citations Shari Pilon‐Thomas, Krithika N. Kodumudi et al. Cancer Research profile →

Peers

Countries citing papers authored by Asmaa El-Kenawi

Since Specialization

Citations

This map shows the geographic impact of Asmaa El-Kenawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asmaa El-Kenawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asmaa El-Kenawi more than expected).

Fields of papers citing papers by Asmaa El-Kenawi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asmaa El-Kenawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asmaa El-Kenawi. The network helps show where Asmaa El-Kenawi may publish in the future.

Co-authorship network of co-authors of Asmaa El-Kenawi

This figure shows the co-authorship network connecting the top 25 collaborators of Asmaa El-Kenawi. A scholar is included among the top collaborators of Asmaa El-Kenawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asmaa El-Kenawi. Asmaa El-Kenawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells 2022 ·Cancer Research ·Asmaa El-Kenawi, Anders Berglund, Verónica Estrella, Yonghong Zhang, (unknown), Ryan M. Putney, Sean Yoder, Joseph Johnson, Joel S. Brown, Robert A. Gatenby	22
2	Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer – A propensity score analysis 2022 ·Prostate Cancer and Prostatic Diseases ·Shivanshu Awasthi, Brandon A. Mahal, Jong Y. Park, (unknown), Vonetta L. Williams, Asmaa El-Kenawi, (unknown), Julio M. Pow‐Sang, Grace L. Lu‐Yao, Wm. Kevin Kelly, (unknown), Janice C. Zgibor, Timothy R. Rebbeck, Kosj Yamoah	4
3	ANPEP: A Potential Regulator of Tumor Cell—Immune Metabolic Interactions in Prostate Cancer of Men of African Descent 2022 ·JCO Global Oncology ·Asmaa El-Kenawi, Shivanshu Awasthi, Amparo Serna, Jasreman Dhillon, Kosj Yamoah	3
4	Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer 2021 ·Cancer Research ·Asmaa El-Kenawi, William Dominguez‐Viqueira, Min Liu, Shivanshu Awasthi, (unknown), (unknown), (unknown), (unknown), Amparo Serna, Jasreman Dhillon, Robert J. Gillies, Xiaoqing Yu, John M. Koomen, Kosj Yamoah, Robert A. Gatenby, Brian Ruffell	68
5	Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma 2021 ·PLoS ONE ·Nicholas H. Chakiryan, (unknown), Youngchul Kim, Ali Hajiran, Ahmet Murat Aydın, Logan Zemp, (unknown), Jonathan V. Nguyen, (unknown), Jad Chahoud, Philippe E. Spiess, Michelle Fournier, Jasreman Dhillon, Liang Wang, Carlos Moran Segura, Asmaa El-Kenawi, James J. Mulé, Philipp M. Altrock, Brandon J. Manley	15
6	T-cells produce acidic niches in lymph nodes to suppress their own effector functions 2020 ·Nature Communications ·Hao Wu, Verónica Estrella, Matthew Beatty, Dominique Abrahams, Asmaa El-Kenawi, Shonagh Russell, Arig Ibrahim‐Hashim, Dario Livio Longo, Yana K. Reshetnyak, Anna Moshnikova, Oleg A. Andreev, Kimberly A. Luddy, Mehdi Damaghi, Krithika N. Kodumudi, Smitha Pillai, Pedro M. Enríquez‐Navas, Shari Pilon‐Thomas, Pawel Swietach, Robert J. Gillies	119
7	The Immune Microenvironment and Cancer Metastasis 2019 ·Cold Spring Harbor Perspectives in Medicine ·Asmaa El-Kenawi, Kay Hänggi, Brian Ruffell	75
8	With macrophages, tumors won’t go hungry 2019 ·Science Translational Medicine ·Asmaa El-Kenawi	3
9	Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer 2019 ·British Journal of Cancer ·Asmaa El-Kenawi, Chandler Gatenbee, Mark Robertson‐Tessi, Rafael Bravo, Jasreman Dhillon, Yoganand Balagurunathan, Anders Berglund, Naveen Kumar Vishvakarma, Arig Ibrahim‐Hashim, Jung Woo Choi, Kimberly A. Luddy, Robert A. Gatenby, Shari Pilon‐Thomas, Alexander R.A. Anderson, Brian Ruffell, Robert J. Gillies	109
10	When T cells lap up lactate 2019 ·Science Translational Medicine ·Asmaa El-Kenawi	4
11	Renoprotective Effect of Agmatine Against Cyclosporin A- Induced Nephrotoxicity in Rats 2018 ·(unknown), Asmaa El-Kenawi, Ghada M. Suddеk, Hatem A. Salem	2
12	Abstract 2695: Role of tumor generated acidity in immune stromal interactions during prostate carcinogenesis 2017 ·Cancer Research ·Asmaa El-Kenawi, Jasreman Dhillon, Arig Ibrahim‐Hashim, Dominique Abrahams, Shari Pilon‐Thomas, Brian Ruffell, Robert A. Gatenby, Robert J. Gillies	1
13	Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy breakdown → 2016 ·Cancer Research ·Shari Pilon‐Thomas, Krithika N. Kodumudi, Asmaa El-Kenawi, Shonagh Russell, Amy Weber, Kimberly A. Luddy, Mehdi Damaghi, Jonathan W. Wojtkowiak, James J. Mulé, Arig Ibrahim‐Hashim, Robert J. Gillies	468
14	Flavocoxid attenuates gentamicin-induced nephrotoxicity in rats 2015 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Dalia H. El‐Kashef, Asmaa El-Kenawi, Ghada M. Suddеk, Hatem A. Salem	22
15	Abstract 3213: Extracellular acidosis alters polarization of macrophages 2015 ·Cancer Research ·Asmaa El-Kenawi, Arig Ibrahim‐Hashim, Kimberly A. Luddy, Shari Pilon‐Thomas, Robert A. Gatenby, Robert J. Gillies	11
16	Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats 2015 ·Canadian Journal of Physiology and Pharmacology ·Dalia H. El‐Kashef, Asmaa El-Kenawi, Mona Abdel Rahim, Ghada M. Suddеk, Hatem A. Salem	22
17	Protective effect of allicin against gentamicin-induced nephrotoxicity in rats 2015 ·International Immunopharmacology ·Dalia H. El‐Kashef, Asmaa El-Kenawi, Ghada M. Suddеk, Hatem A. Salem	48
18	Abstract 4560: Effects of cisplatin, vorinostat, and their combinations on EGFR-overexpressing cell lines 2014 ·Cancer Research ·Asmaa El-Kenawi, John K. Cowell	1
19	Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales 2013 ·British Journal of Pharmacology ·Asmaa El-Kenawi, Azza B. El‐Remessy	202
20	Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity 2011 ·Chemotherapy ·Ghada M. Suddеk, Asmaa El-Kenawi, Azza Abdel‐Aziz, Hassan A. El‐Kashef	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact